The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccrol Gp Regulatory News (ACRL)

Share Price Information for Accrol Gp (ACRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 38.60
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.10 (0.259%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 38.60
ACRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors' Dealings

11 Dec 2017 08:02

RNS Number : 8760Y
Accrol Group Holdings PLC
11 December 2017
 

11 December 2017

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

Accrol Group Holdings plc

(AIM: ACRL)

 

Directors' Dealings

 

Accrol Group Holdings plc (the "Company" or "Accrol"), the AIM-listed leading independent tissue converter, is pleased to announce that certain directors of Accrol have, pursuant to the Placing (as described in the Company's announcement of 20 November 2017 titled "Proposed Placing of £18m and Lifting of Suspension"), in aggregate purchased 400,000 ordinary shares of £0.001 each ("Ordinary Shares") at a price of 50p per Ordinary Share as set out below.

 

 

 

 

 

Name

 

 

 

 

Title

 

 

 

Number of Shares

 

 

 

Value of Shares

 

 

 

Resulting Shareholding

Percentage of Enlarged Share Capital

 

 

 

 

 

 

Peter Cheung

Chairman

50,000

£25,000

661,683

0.51%

Gareth Jenkins

CEO

100,000

£50,000

100,000

0.08%

Steve Hammett

Non-executive Director

40,000

£20,000

40,000

0.03%

Joanne Lake

Non-executive Director

10,000

£5,000

35,000

0.03%

Dan Wright

Non-executive Director

200,000

£100,000

200,000

0.16%

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

i) Peter Cheung

ii) Gareth Jenkins

iii) Steve Hammett

iv) Joanne Lake

v) Dan Wright

2

Reason for the notification

a)

Position/status

i) Chairman

ii) Chief Executive Officer

iii) Non-executive Director

iv) Non-executive Director

v) Non-executive Director

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Accrol Group Holdings plc

b)

LEI

213800MC56M5G69RJ226

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of £0.001

 

ISIN: GB00BZ6VT592

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

50p

 

Volume(s)

i) 50,000

ii) 100,000

iii) 40,000

iv) 10,000

v) 200,000

d)

Aggregated information

- Aggregated volume

- Price

N/A - single transaction

e)

Date of the transaction

11 December 2017

f)

Place of the transaction

London Stock Exchange, AIM

 

Enquiries:

 

Accrol Group Holdings plc Tel: +44 (0) 1254 278 844

Gareth Jenkins, CEO

James Flude, Finance Director

 

Zeus Capital Limited (Nominated Adviser & Broker)

Dan Bate / Andrew Jones Tel: +44 (0) 161 831 1512

Dominic King / John Goold Tel: +44 (0) 203 829 5000

 

Belvedere Communications Limited Tel: +44 (0) 203 567 0510

Cat Valentine (cvalentine@belvederepr.com) Mob: +44 (0) 7715 769 078

Kim van Beeck (kvbeeck@belvederepr.com) Mob: +44 (0) 7477 967 446

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHFMMGZVRZGNZM
Date   Source Headline
9th Jun 202311:43 amRNSTR-1
16th May 20237:00 amRNSTrading Update
2nd May 20237:00 amRNSBoard Changes
18th Apr 20234:40 pmRNSTR-1
27th Mar 20233:22 pmRNSTR-1
24th Mar 20231:38 pmRNSTR-1
7th Mar 20237:00 amRNSAppointment of Joint Broker
1st Mar 20237:00 amRNSLicensing Agreement with Unilever
27th Jan 20231:27 pmRNSTR-1
24th Jan 20237:00 amRNSHalf Year Results
24th Jan 20237:00 amRNSStrategic Review Outcomes
11th Jan 20237:00 amRNSNotice: Results, Strategic Review & Presentations
20th Dec 20227:00 amRNSDirector Dealing
28th Nov 20221:36 pmRNSLaunch of second ESG Report
21st Nov 20227:00 amRNSHalf Year Trading Update
18th Nov 20227:00 amRNSAwards under LTIP and PDMR dealing
18th Oct 20221:27 pmRNSResult of 2022 Annual General Meeting
23rd Sep 20227:38 amRNSNotice of AGM and Posting of Annual Report 2022
20th Sep 20224:41 pmRNSSecond Price Monitoring Extn
20th Sep 20224:36 pmRNSPrice Monitoring Extension
6th Sep 20227:00 amRNSAudited Final Results
10th Aug 20227:00 amRNSNotice of Final Results and Online Presentations
31st May 202212:21 pmRNSTR-1
17th May 20227:00 amRNSTrading Update - FY22 in line with expectations
10th May 202211:57 amRNSTR-1
7th Apr 20227:00 amRNSTR-1
15th Mar 20223:58 pmRNSTR-1
14th Mar 20227:00 amRNSUpdate on LTC Share Purchase Agreement
11th Mar 20224:41 pmRNSSecond Price Monitoring Extn
11th Mar 20224:36 pmRNSPrice Monitoring Extension
4th Mar 20227:00 amRNSDirector Dealing
24th Feb 20223:45 pmRNSTR-1
24th Feb 20227:00 amRNSAwards under LTIP and PDMR dealing
11th Feb 202212:40 pmRNSTR-1
3rd Feb 20221:59 pmRNSTR-1
2nd Feb 202211:08 amRNSTR-1
21st Jan 20222:42 pmRNSTR-1
18th Jan 20227:00 amRNSHalf Year Results
17th Jan 20226:18 pmRNSTR-1
17th Jan 20223:13 pmRNSTR-1
12th Jan 20227:00 amRNSTrading Update
16th Dec 20217:00 amRNSNotice of Results and Online Investor Presentation
20th Oct 20217:00 amRNSTrading Update
28th Sep 20219:46 amRNSLaunch of ESG Report
24th Sep 202111:59 amRNSResult of AGM
27th Aug 20211:32 pmRNSNotice of AGM and Posting of Annual Report 2021
28th Jul 20215:30 pmRNSTR-1
23rd Jul 20212:35 pmRNSDirector Share Purchase
23rd Jul 20212:31 pmRNSExercise of Options, Director Dealings and TVR
16th Jul 20214:37 pmRNSDirector Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.